US FDA accepts application for psoriasis drug: Sun Pharma
Drug major Sun Pharmaceutical Industries on Wednesday said the US health regulator has accepted biologics licence application (BLA) for tildrakizumab for the treatment of psoriasis.
May 24, 2017, 11:49 AM IST